Psychiatry · South Charleston, WV
NPI
1518083328
Since 2007
Specialty
Psychiatry
Code 2084P0800X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
312 6th Ave Ste 2
South Charleston, WV, 25303
Phone (304) 768-6170
Groups this clinician bills Medicare through
Medicare paid, 2024
$121K
1,447 services
Medicare patients, 2024
235
Average age 67
Drug cost, 2024
$1.3M
6,068 prescriptions
Company payments, 2025
$140K
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel B Thistlethwaite was code 99214 (office e&m - established), 831 times for 210 patients. In total Daniel B Thistlethwaite billed 1,447 services in 18 codes, and Medicare paid $121K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-06-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 831 | 210 | $74.28 | $62K |
| 90868 Treatment - Miscellaneous | Office | 297 | 13 | $115.18 | $34K |
| 90837 Psychotherapy - Nongroup | Office | 89 | 26 | $86.61 | $7,708 |
| 99213 Office E&M - Established | Office | 20 | 19 | $58.21 | $1,164 |
| 99205 Office E&M - New | Office | 13 | 13 | $151.79 | $1,973 |
| 99204 Office E&M - New | Office | 11 | 11 | $98.58 | $1,084 |
By year: 2022 $254K for 2,615 services; 2023 $256K for 2,021 services; 2024 $121K for 1,447 services.
Medicare prescription drug claims, 2024
In 2024, the drug Daniel B Thistlethwaite prescribed most often to Medicare patients was Alprazolam, with 597 prescriptions and refills. In total Daniel B Thistlethwaite wrote 6,068 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Alprazolam Generic | 597 | 694 | 116 | $2,874 |
| Clonazepam Generic | 418 | 482 | 63 | $2,818 |
| Trazodone Hcl Generic | 300 | 607 | 73 | $2,246 |
| Buspirone Hcl Generic | 289 | 553 | 63 | $4,589 |
| Lorazepam Generic | 254 | 288 | 55 | $1,565 |
| Desvenlafaxine Succinate Er Desvenlafaxine Succinate | 247 | 489 | 49 | $21K |
| Lamotrigine Generic | 225 | 510 | 51 | $2,345 |
| Duloxetine Hcl Generic | 218 | 522 | 55 | $4,243 |
| Escitalopram Oxalate Generic | 192 | 438 | 47 | $2,156 |
| Mirtazapine Generic | 184 | 419 | 47 | $3,134 |
| Sertraline Hcl Generic | 178 | 408 | 46 | $1,630 |
| Aripiprazole Generic | 165 | 365 | 51 | $12K |
| Quetiapine Fumarate Generic | 164 | 360 | 43 | $2,919 |
| Bupropion Xl Bupropion Hcl | 162 | 352 | 42 | $3,442 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 145 | 291 | 26 | $5,262 |
Brand drugs: 636 claims; generic drugs: 5,432 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel B Thistlethwaite $140K ($140K in general payments such as food, travel and fees) from 14 companies. The largest payer was Otsuka America Pharmaceutical, Inc. with $42K.
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. 4578.T | 52 | $42K |
| Alkermes, Inc. ALKS | 39 | $33K |
| Axsome Therapeutics, Inc. AXSM | 33 | $32K |
| Janssen Pharmaceuticals, Inc JNJ | 32 | $25K |
| Abbvie Inc. ABBV | 11 | $8,125 |
| Teva Pharmaceuticals USA, Inc. TEVA | 10 | $225 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $175 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 12 | $158 |
| Lundbeck LLC | 6 | $112 |
| Tris Pharma Inc | 4 | $89.48 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.